Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingyue He

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|January 8, 2020
[Expression of miR-155-5p in Wilms tumor and its regulatory role in proliferation, migration and apoptosis of Wilms tumor cells <i>in vitro</i>]Xin Luo, Junjun Dong, Xingyue He, et al.
Plos One|April 11, 2015
Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferationXingyue He, Jessica Riceberg, Sai M Pulukuri, et al.
RSC Advances|July 6, 2026
Synergistic dual-surface passivation <i>via</i> 1-butyl-3-methylimidazolium iodide for efficient and stable inverted CsPbI<sub>2</sub>Br perovskite solar cellsXin Liu, Chengguo Liu, Lang Wang, et al.
International Journal of Nanomedicine|June 9, 2022
Cefquinome Sulfate Oily Nanosuspension Designed for Improving its Bioavailability in the Treatment of Veterinary InfectionsYujuan Mao, Yumeng Chen, Chang Liu, et al.
Life Sciences|January 31, 2024
IL-13 alleviates acute kidney injury and promotes regeneration via activating the JAK-STAT signaling pathway in a rat kidney transplantation modelChengjun Yu, Jie Zhang, Jun Pei, et al.
Genes & Development|February 18, 2014
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppressionNobuhiro Okada, Chao-Po Lin, Marcelo C Ribeiro, et al.
Nature Cell Biology|October 25, 2011
miR-34 miRNAs provide a barrier for somatic cell reprogrammingYong Jin Choi, Chao-Po Lin, Jaclyn J Ho, et al.
Nature|June 8, 2007
A microRNA component of the p53 tumour suppressor networkLin He, Xingyue He, Lee P Lim, et al.
EMBO Molecular Medicine|May 18, 2018
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerabilityKenichi Iwai, Masahiro Yaguchi, Kazuho Nishimura, et al.
Nature Chemical Biology|September 12, 2017
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|January 8, 2020
[Expression of miR-155-5p in Wilms tumor and its regulatory role in proliferation, migration and apoptosis of Wilms tumor cells <i>in vitro</i>]Xin Luo, Junjun Dong, Xingyue He, et al.
Plos One|April 11, 2015
Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferationXingyue He, Jessica Riceberg, Sai M Pulukuri, et al.
RSC Advances|July 6, 2026
Synergistic dual-surface passivation <i>via</i> 1-butyl-3-methylimidazolium iodide for efficient and stable inverted CsPbI<sub>2</sub>Br perovskite solar cellsXin Liu, Chengguo Liu, Lang Wang, et al.
International Journal of Nanomedicine|June 9, 2022
Cefquinome Sulfate Oily Nanosuspension Designed for Improving its Bioavailability in the Treatment of Veterinary InfectionsYujuan Mao, Yumeng Chen, Chang Liu, et al.
Life Sciences|January 31, 2024
IL-13 alleviates acute kidney injury and promotes regeneration via activating the JAK-STAT signaling pathway in a rat kidney transplantation modelChengjun Yu, Jie Zhang, Jun Pei, et al.
Genes & Development|February 18, 2014
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppressionNobuhiro Okada, Chao-Po Lin, Marcelo C Ribeiro, et al.
Nature Cell Biology|October 25, 2011
miR-34 miRNAs provide a barrier for somatic cell reprogrammingYong Jin Choi, Chao-Po Lin, Jaclyn J Ho, et al.
Nature|June 8, 2007
A microRNA component of the p53 tumour suppressor networkLin He, Xingyue He, Lee P Lim, et al.
EMBO Molecular Medicine|May 18, 2018
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerabilityKenichi Iwai, Masahiro Yaguchi, Kazuho Nishimura, et al.
Nature Chemical Biology|September 12, 2017
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Jessica Riceberg, Teresa Soucy, et al.
Pageof 5